Nerve Therapy in Modesto, CA: Supportive Protocols for Peripheral Neuropathy, Sciatica, and Neural Pain

Medically reviewed by Jeff Steckler, OTD, OTR/L — Doctor of Occupational Therapy with 38+ years of clinical experience. Last reviewed: May 17, 2026.


The Short Answer

Nerve therapy at Advanced Recovery Cryotherapy (ARC) is a structured set of supportive, adjunctive modalities — whole-body cryotherapy, localized cryotherapy, Class IV laser, Infrared Cocoon, NeuralChek + BrainTap, and Graston/IASTM — used alongside your physician and neurologist to help manage symptoms of peripheral neuropathy, sciatica, and other neural pain conditions. ARC is not a diagnostic clinic, and our protocols are not a replacement for neurological evaluation or prescribed medical care. We work in the recovery and symptom-management space, in coordination with your medical team.

Advanced Recovery Cryotherapy (ARC), founded 2018 by Jeff and Anna Steckler, OTD, OTR/L, at 4660 Spyres Way, Modesto, CA 95356, is Central Valley’s only purpose-built clinical recovery facility — over 2,000 clients served across athletic, chronic pain, post-surgical, and neuropathy populations since opening.

Cryotherapy’s mechanisms — peripheral vasoconstriction, a norepinephrine surge, and a parasympathetic shift — are well-characterized in the recovery literature and provide the foundational rationale for cold-based protocols in pain populations (PMID: 33877402). Direct randomized trial evidence for cryo and laser specifically in peripheral neuropathy populations is still emerging, so ARC’s protocols are framed honestly: mechanism-grounded, observation-informed, and always positioned as supportive of — not a substitute for — physician-directed neuropathy care.

This page covers what nerve therapy actually means clinically, the modalities ARC offers in this space, who tends to benefit, Central Valley context, safety contraindications (including a critical note on diabetic neuropathy and cryotherapy), and answers to the most common questions we hear from clients navigating neural pain.


What Nerve Therapy Actually Means

“Nerve therapy” is an umbrella term that covers a wide range of conditions, mechanisms, and clinical pathways. Before exploring how ARC fits in, it’s worth grounding the terminology — because the right adjunctive support looks different depending on what kind of nerve pain you’re dealing with.

Sensory vs. Motor Neuropathy

Sensory neuropathy involves damage to nerves that carry sensation. Symptoms include burning, tingling, numbness, pins-and-needles, hypersensitivity to touch, and sometimes loss of temperature or vibration perception. Sensory neuropathy is the most common pattern we see in clients walking through our doors — particularly in feet and hands.

Motor neuropathy involves damage to nerves that control muscle movement. Symptoms include muscle weakness, cramping, twitching, and in advanced cases, muscle atrophy. Motor symptoms warrant immediate neurological evaluation if new or progressing.

Autonomic neuropathy — damage to nerves controlling involuntary functions like heart rate, digestion, and blood pressure regulation — is a third category that requires specialist management and is outside ARC’s scope as a supportive recovery facility.

Most clients present with a mixed sensory-motor picture, which is why protocols always start with what their physician or neurologist has already established about the diagnosis.

Central vs. Peripheral

Peripheral neuropathy involves nerves outside the brain and spinal cord — typically affecting feet, legs, hands, and arms. This is the population ARC most commonly supports.

Central nerve pain involves the brain or spinal cord directly — conditions like central post-stroke pain, multiple sclerosis-related neuropathy, or spinal cord injury pain. Central pain syndromes are complex, require specialist management, and are not the focus of ARC’s nerve therapy protocols. Some of the nervous-system regulation work (BrainTap, NeuralChek) may offer supportive benefit in central conditions, but always in close coordination with the treating neurologist.

Common Causes of Peripheral Neuropathy

Peripheral neuropathy isn’t a diagnosis on its own — it’s a description of nerve dysfunction caused by an underlying condition. The most common causes ARC sees in our Central Valley clientele:

Diabetic peripheral neuropathy. The leading cause of peripheral neuropathy in the United States. Chronically elevated blood glucose damages small nerve fibers, most commonly producing symmetric burning and numbness in the feet (stocking-glove distribution). Stanislaus County’s diabetes prevalence — driven by demographic and socioeconomic factors discussed below — makes this the single largest neuropathy population we serve.

Chemotherapy-induced peripheral neuropathy (CIPN). Several common chemotherapy agents (platinum-based drugs, taxanes, vinca alkaloids, bortezomib) cause peripheral nerve damage that can persist or progress for months to years after treatment ends. Many of our chemo-recovery clients arrive with residual neuropathy after their oncology team has discharged them from active treatment.

Idiopathic peripheral neuropathy. A diagnosis of exclusion when workup fails to identify a specific cause. Often presents in adults over 50 with gradually progressive sensory symptoms.

Post-surgical nerve injury. Nerve compression, traction, or transection during surgery — common after major joint replacements, spinal procedures, and abdominal/pelvic surgery. Many post-surgical clients combine our post-surgery recovery protocols with nerve-focused work.

Sciatica and radicular pain. Compression or irritation of the sciatic nerve (or individual lumbar nerve roots) producing pain, numbness, or weakness radiating down the leg. Mechanically and clinically distinct from peripheral neuropathy — though both fall under the “nerve pain” umbrella, the supportive protocols look very different (more on this below).

Other causes. Alcohol-related neuropathy, B12 deficiency, autoimmune conditions (CIDP, GBS, Sjögren’s), HIV-related neuropathy, toxic exposures, and many others. The underlying cause matters because it dictates which medical specialist is managing the condition and what adjunctive support is appropriate.

What “Nerve Therapy” Means at ARC Specifically

Within this landscape, ARC’s role is supportive — we offer modalities that may help manage symptoms (pain, burning, tightness, sleep disruption, nervous-system stress) alongside the medical care directed by your physician or neurologist. We don’t diagnose neuropathy. We don’t prescribe medications. We don’t replace neurological workup. What we offer is a clinical recovery environment where evidence-grounded modalities are layered thoughtfully under licensed clinician supervision, with full disclosure of where the evidence is strong and where it’s still emerging.


ARC’s Core Nerve Therapy Modalities

Six modalities form the backbone of ARC’s supportive nerve-therapy protocols. The right combination depends on diagnosis, symptom pattern, circulation status, comorbidities, and what your medical team has already established. Every nerve-therapy client at ARC completes an intake that captures these inputs before any modality is recommended.

1. Whole-Body Cryotherapy — Systemic Anti-Inflammatory + Nervous System Reset

What it is: 2–3 minutes in an electric cryo cabin at −200°F to −250°F. The extreme cold triggers rapid peripheral vasoconstriction, a norepinephrine surge, and a systemic anti-inflammatory response. Importantly, post-session re-warming produces a rebound vasodilation and a parasympathetic shift that many clients describe as a “nervous system reset.”

Mechanism in the nerve pain context: The Kwiecien 2021 review on cryotherapy mechanisms documents the norepinephrine surge, cytokine modulation, and parasympathetic shift that follow whole-body cold exposure — mechanisms with plausible application in chronic pain management and recovery contexts (PMID: 33877402). Direct randomized-trial evidence for whole-body cryo specifically reducing peripheral neuropathy symptoms is still emerging — we don’t claim cryo “treats” neuropathy. What we do see clinically is many clients reporting reduced overall pain perception, better sleep quality, and a calmer nervous system on weeks they include 2–3 cryo sessions.

When it’s appropriate: Clients with peripheral neuropathy who have adequate circulation (cleared by their physician), no Raynaud’s phenomenon, no severe uncontrolled diabetes, no recent cardiac event, and tolerance for the cabin environment. When it’s contraindicated: See the safety section below — severe peripheral neuropathy with compromised circulation is a hard contraindication.

How ARC uses it: Typically 2–3× per week during symptom flares, dropped to 1× per week as a maintenance protocol once symptoms stabilize. Always paired with a thorough circulation check at intake. See our Whole Body Cryotherapy service page for what to expect.

2. Localized Cryotherapy — Targeted Analgesia for Specific Nerve Pain

What it is: Direct cold application to a specific area of the body using a precision cold-air device. Sessions run 5–10 minutes per area and deliver focused cold without the systemic stress of a full cabin session.

Why it matters for nerve pain: When peripheral neuropathy or sciatica is concentrated in a specific region — feet, calves, lumbar paraspinals, hands — localized cryo can deliver the analgesic and anti-inflammatory effects of cold therapy directly to the symptomatic area, without the systemic exposure that whole-body cryo requires. This makes localized cryo a viable option for some clients whose comorbidities preclude full cabin sessions. The Malanga 2015 review of heat and cold therapy mechanisms provides the foundational rationale for targeted cold protocols in musculoskeletal and neural pain (PMID: 25526231).

When it’s appropriate: Localized neural pain flares, post-exercise nerve irritation, sciatic radicular pain, sensitive areas where whole-body exposure is uncomfortable. Localized cryo is often the modality of choice for diabetic clients where systemic cryo may be contraindicated — but a circulation check is still required before the area is treated.

How ARC uses it: Layered with Class IV laser and/or IASTM on the same visit for clients with localized neural pain components. See Localized Cryotherapy services for details.

3. Class IV Laser — Photobiomodulation for Tissue Healing and Pain Reduction

What it is: High-power therapeutic laser delivering photobiomodulation energy to targeted tissues. The laser stimulates cellular ATP production, modulates inflammation pathways, and reduces pain through multiple neural mechanisms. Sessions target specific areas — feet, hands, lumbar spine, posterior leg — for 10–20 minutes.

Mechanism in the nerve pain context: The 2015 Malanga review documents the foundational mechanisms of photobiomodulation in tissue healing and pain modulation (PMID: 25526231). For peripheral neuropathy specifically, the mechanistic rationale rests on photobiomodulation’s effects at the cellular level (mitochondrial ATP production, reactive oxygen species modulation) and on its analgesic effects via neural pathway modulation. Direct large-scale RCT evidence for Class IV laser in peripheral neuropathy is still building, so we frame Class IV laser as a mechanism-grounded supportive modality that many of our clients find genuinely useful — without overclaiming.

When it’s appropriate: Peripheral neuropathy with localized symptom concentration (feet, hands), sciatica with discrete dermatomal patterns, post-surgical nerve recovery, chronic radicular pain. Particularly valuable for clients who want to reduce pharmaceutical pain medication reliance in coordination with their physician.

How ARC uses it: Most commonly applied bilaterally to the feet for diabetic and chemo-induced neuropathy, or focused on the lumbar paraspinals and posterior leg for sciatic radicular pain. Typical course: 2–3× per week for 6–12 weeks, then reassess. Often combined with IASTM for clients with neural pain that has a soft-tissue component.

4. Infrared Cocoon — Thermal Therapy for Circulation and Comfort

What it is: Far-infrared thermal therapy delivered in a fitness-pod configuration. The infrared wavelengths produce deep thermal penetration that supports peripheral circulation, parasympathetic activation, and overall comfort. Sessions run 30–45 minutes.

Why it matters for nerve pain: Many peripheral neuropathy clients experience cold extremities, reduced peripheral circulation, and generalized muscle tightness that compounds neural symptoms. Far-infrared thermal therapy can support peripheral circulation and provide a deeply relaxing nervous-system experience for clients whose neuropathic pain is amplified by stress and poor sleep. It also gives clients who are contraindicated for whole-body cryo an alternative pathway to access nervous-system regulation effects.

When it’s appropriate: Most peripheral neuropathy clients tolerate infrared cocoon well. The notable exception: clients with autonomic neuropathy affecting heat regulation should clear infrared use with their physician first, since thermoregulatory impairment can elevate risk during prolonged thermal exposure.

How ARC uses it: Often paired with NeuralChek + BrainTap in the same visit for clients prioritizing nervous-system regulation. See Infrared Cocoon services for details.

5. NeuralChek + BrainTap — Nervous-System Regulation

What it is: A pairing of NeuralChek (a brain-mapping assessment that captures objective markers of nervous-system state) with BrainTap (a guided audio-visual brainwave entrainment session). Together they provide an assessment-plus-intervention pathway for clients whose neural pain is exacerbated by sympathetic-dominant nervous-system patterns, chronic stress, and poor sleep.

Mechanism in the nerve pain context: Chronic pain — particularly neuropathic pain — is amplified by sympathetic nervous-system activation, sleep disruption, and the stress-pain feedback loop that develops in long-duration conditions. Modalities that support parasympathetic shift, downregulate sympathetic tone, and improve sleep quality can meaningfully reduce the suffering component of chronic neural pain even when the underlying nerve damage is unchanged. Maizes 2017 review of integrative health service delivery found multi-modal treatment plans produced 30–45% greater improvement on patient-reported outcomes vs single-modality approaches across eight studies, supporting the broader case for layering nervous-system regulation onto symptom-management protocols (PMID: 29056410).

When it’s appropriate: Most nerve-pain clients benefit from at least an introductory NeuralChek assessment to understand their baseline nervous-system state. BrainTap sessions are particularly valued by clients whose neuropathy is disrupting sleep and producing the secondary anxiety and fatigue that often accompany chronic neural pain.

How ARC uses it: Initial NeuralChek assessment at intake for nerve-pain clients, with BrainTap sessions integrated into ongoing visits for those who benefit. See NeuralChek & BrainTap services for the full picture.

6. Graston Technique / IASTM — Soft Tissue Mobilization for Neural-Muscular Components

What it is: Instrument-assisted soft tissue mobilization (IASTM) using specialized tools to address fascial adhesions, scar tissue, and chronic soft-tissue restrictions that contribute to neural tension. Graston is one of the most well-known IASTM systems.

Why it matters for nerve pain: Many nerve-pain presentations — particularly sciatica and post-surgical neural pain — involve a substantial muscular and fascial component. Tight piriformis, hamstring, and lumbar paraspinal tissue can compress or irritate neural structures and amplify symptoms. IASTM can address those soft-tissue components directly, which often reduces the neural symptom load even when the primary nerve pathology is unchanged. The Coviello 2017 systematic review of IASTM found moderate evidence for improvements in range of motion, pain reduction, and functional outcomes — strongest when IASTM was combined with therapeutic exercise rather than used alone (PMID: 28349028).

When it’s appropriate: Sciatica with clear muscular tension components (piriformis syndrome, hamstring tightness contributing to neural tension), post-surgical nerve pain where scar tissue is part of the picture, chronic neural pain syndromes with concurrent myofascial restrictions. When it’s contraindicated: Clients on blood thinners (relative contraindication — deep work avoided), active skin breakdown in the treatment area, sensory neuropathy severe enough that pressure sensation is unreliable (since IASTM relies on client feedback to titrate pressure safely).

How ARC uses it: Commonly the lead modality for sciatica protocols, paired with Class IV laser and localized cryo. Less central for diabetic and chemo-induced neuropathy, where the primary pathology is at the nerve fiber level rather than in surrounding soft tissue. See Graston Technique & IASTM services.


Head-to-Head Comparison of Nerve Therapy Modalities

The table below compares the supportive modalities at ARC alongside prescription neuropathy medications — not as competitors, but to clarify where each fits. Prescription medications remain your physician’s domain; ARC’s modalities support the symptom-management picture alongside whatever your medical team has prescribed.

Modality Best For Mechanism Session Length Frequency Evidence Level
Whole-Body Cryotherapy Systemic pain modulation, nervous-system reset Vasoconstriction, norepinephrine surge, parasympathetic shift 2–3 min 1–3× per week Mechanism well-characterized for recovery (PMID: 33877402); direct neuropathy RCTs still emerging
Localized Cryotherapy Targeted neural pain (feet, hands, sciatic area) Local analgesia, focal anti-inflammatory 5–10 min per area 1–3× per week Mechanism review (PMID: 25526231); supportive for localized symptoms
Class IV Laser Peripheral neuropathy in feet/hands, sciatica, post-surgical nerve pain Photobiomodulation, cellular ATP, analgesia 10–20 min 2–3× per week for 6–12 weeks Mechanism review (PMID: 25526231); emerging RCT evidence in neuropathy populations
IASTM / Graston Sciatica, neural pain with muscular component Instrument-assisted fascial release 15–20 min 1–2× per week Systematic review (PMID: 28349028) — best combined with exercise
Compression Therapy Adjunctive circulation support (cleared cases only) Mechanical venous/lymphatic return 20–30 min 1–2× per week Multiple RCTs in recovery (PMID: 23315753, 34234090); use cautiously in neuropathy with circulation compromise
NeuralChek / BrainTap Nervous-system regulation, sleep, stress-pain loop Brain-state assessment + brainwave entrainment 20–30 min 1–2× per week Multi-modal integrative care evidence (PMID: 29056410)
Infrared Cocoon Circulation support, relaxation, nervous-system regulation Far-infrared thermal penetration 30–45 min 1–2× per week Mechanism-supported thermal therapy; supportive, not a treatment
Prescription neuropathy meds (gabapentin, pregabalin, duloxetine, others) Pharmacological pain control per physician guidance Various — neural calcium channel modulation, serotonin/norepinephrine reuptake Daily oral dose Per physician prescription Your physician’s domain — extensive RCT evidence supports use in specific neuropathy diagnoses

The bottom row matters: prescription neuropathy medications are evidence-based pharmacological tools managed by your physician. We don’t position ARC’s modalities “vs” gabapentin or duloxetine. We position them alongside — as supportive options that may reduce overall symptom burden, support better sleep and circulation, and help with the secondary effects of chronic neural pain. Many of our clients use both ARC services and prescription medications. Many find that adjunctive support allows productive conversations with their physician about dosing. That’s a conversation for them and their physician, not for ARC.


Who ARC Serves — Nerve Therapy Populations in Central Valley

ARC supports four primary populations in the nerve-therapy space, each with distinct clinical considerations and protocol patterns.

Diabetic peripheral neuropathy clients. The largest population we see in this category. Most arrive after their physician has confirmed neuropathy through symptom evaluation, possibly EMG/NCS testing, and standard care recommendations (glucose control optimization, possibly gabapentin or duloxetine). Many have plateaued on prescription management and are seeking adjunctive support for symptom management — particularly burning and tingling in the feet that disrupts sleep. Protocols emphasize localized cryotherapy and Class IV laser bilaterally to the feet, NeuralChek + BrainTap for sleep and nervous-system support, and Infrared Cocoon for circulation support. Whole-body cryo is offered only after a careful circulation assessment and physician clearance — and many diabetic neuropathy clients are best served with the localized + laser pathway rather than full cabin exposure.

Chemotherapy-induced peripheral neuropathy (CIPN) clients. A growing population as cancer survivorship grows. Many of our CIPN clients arrive after oncology discharge, with residual neuropathy in feet and hands that has persisted months to years after treatment ended. Symptoms range from mild tingling to severe burning and functional impairment. Protocols are gentle initially — Class IV laser on the most symptomatic areas, NeuralChek + BrainTap for the stress-pain loop and sleep disruption, with whole-body or localized cryo introduced cautiously once tolerance is established. Always in coordination with the oncology team where the survivorship plan is still active.

Sciatica and lumbar radicular pain clients. Distinct mechanically from peripheral neuropathy — typically driven by lumbar disc, facet, or muscular compression of neural structures rather than diffuse nerve fiber damage. Protocols emphasize IASTM to address muscular tension components, Class IV laser on the lumbar paraspinals and along the sciatic distribution, localized cryotherapy for acute flares, and assisted stretching for mobility restoration. Whole-body cryo serves as an adjunct for systemic pain modulation but isn’t the lead modality.

Post-surgical nerve recovery. Clients dealing with residual neural symptoms after major surgery — knee or hip replacement, spinal procedures, abdominal/pelvic surgery, mastectomy, or other procedures that involved nerve manipulation, traction, or transection. Protocols combine nerve-focused modalities with the broader post-surgery recovery framework — Class IV laser on the surgical region and downstream neural distribution, localized cryotherapy on flare areas, IASTM for adhesion management once incisions are healed and surgeon has cleared deeper work, and BrainTap for the nervous-system regulation often disrupted after major procedures.

What all four populations share: a medical team already managing the primary condition, a desire for adjunctive support that doesn’t conflict with that medical plan, and the need for a clinical environment that takes their condition seriously rather than treating them as athletic recovery clients. ARC’s protocols are designed exactly for that need.


The Central Valley Nerve Therapy Context

Central Valley demographics and labor patterns produce a specific nerve-pain landscape that differs from coastal California or urban metro areas. Understanding that context matters for how we design and offer supportive protocols.

Diabetes prevalence in Stanislaus County. Stanislaus County and the broader Central Valley have higher rates of type 2 diabetes than the California state average — driven by demographic factors, socioeconomic factors, and dietary patterns common to the region. Diabetic peripheral neuropathy is correspondingly more common here than in many California regions, and many local clients have been navigating diabetic neuropathy for years before discovering that supportive recovery modalities exist outside the prescription pharmacy.

Agricultural labor neuropathy patterns. The Central Valley is the agricultural heart of California, and a substantial portion of our local workforce performs physically demanding agricultural and warehouse labor — often with cumulative repetitive-stress injuries, peripheral nerve compression patterns (carpal tunnel, ulnar entrapment, thoracic outlet), and lumbar disc issues producing sciatic pain. These nerve-pain patterns are mechanically driven and respond meaningfully to a combination of IASTM, Class IV laser, and localized cryotherapy — modalities not typically accessible to this workforce through standard insurance pathways.

Post-chemo recovery clients. Modesto and the surrounding region have several established oncology programs serving the broader Central Valley. As cancer survival rates have improved, the survivor population has grown — and a substantial subset live with residual chemotherapy-induced peripheral neuropathy. Until recently, these clients had few local options for adjunctive symptom management beyond pharmaceutical pain control. ARC fills a meaningful gap for this population.

Healthcare access patterns. Specialist access (neurology in particular) can involve long wait times and significant travel for Central Valley residents. Many clients arrive at ARC having waited months for a neurology appointment, or having been told that there’s “nothing more” their physician can offer beyond current prescriptions. We don’t replace the neurologist — but for clients on long wait lists or plateaued on current care, we offer a clinical setting where supportive options exist now.

Temperature extremes. Summer heat at 100°F+ exacerbates neuropathic symptoms in many clients — burning sensations intensify, fluid balance affects nerve symptoms, and sleep disruption compounds the pain experience. Winter Tule fog and damp cold often worsen sciatic and arthritic neural pain. Cryotherapy and infrared thermal therapy provide environmental counter-regulation that’s particularly valuable in a region with these temperature extremes.

Cash-pay clinical wellness as a meaningful option. The traditional model — primary care plus specialist plus pharmacy — works for the diagnostic and pharmacological side of neuropathy management. The supportive recovery side has historically been less developed for adults outside the pro-athlete world. ARC’s existence as a purpose-built clinical recovery facility, accessible through self-pay without referral or insurance hurdles, fills exactly that gap.


What a Sample Nerve Therapy Week Might Look Like

Different conditions and stages produce different protocol patterns. Below are four representative weekly structures, each calibrated to the underlying condition. These are starting templates — real protocols at ARC are individualized after intake.

Diabetic Peripheral Neuropathy — Active Symptom Management Phase:
– Monday: Class IV laser bilaterally to feet (15 min) + Infrared Cocoon (30 min).
– Wednesday: Localized cryotherapy to feet (10 min) + NeuralChek check-in + BrainTap (20 min).
– Friday: Class IV laser bilaterally to feet (15 min) + Infrared Cocoon (30 min).
– Saturday: Optional whole-body cryotherapy (if circulation cleared) OR rest day.
– Maintenance phase: drop to 1× per week of laser + cocoon once symptoms stabilize.

Chemotherapy-Induced Peripheral Neuropathy — Post-Treatment Recovery:
– Tuesday: Class IV laser to most symptomatic areas (feet and/or hands, 15–20 min) + BrainTap (20 min).
– Thursday: Infrared Cocoon (30–45 min) + NeuralChek check-in.
– Saturday: Class IV laser repeat + optional localized cryo to specific flare areas.
– Reassess every 4 weeks with oncology team’s awareness; adjust intensity based on tolerance and progress.

Sciatica / Lumbar Radicular Pain — Acute Flare Management:
– Monday: IASTM on lumbar paraspinals + glutes (20 min) + Class IV laser on lumbar spine and posterior leg (15 min).
– Wednesday: Localized cryotherapy on lumbar region (10 min) + assisted stretching (20 min).
– Friday: Repeat Monday protocol.
– Sunday: BrainTap for nervous-system reset + optional Infrared Cocoon.
– Transition to maintenance (1–2× per week) once acute flare resolves; emphasize home exercise and posture work in coordination with PT or physician.

Post-Surgical Nerve Recovery — Weeks 6–12 Post-Op (Surgeon Cleared):
– Tuesday: Class IV laser on surgical region and downstream neural distribution (15 min) + localized cryo on flare areas (10 min).
– Thursday: BrainTap (20 min) + Infrared Cocoon (30 min) for nervous-system regulation.
– Saturday: Class IV laser repeat + IASTM on healed soft tissue (only with surgeon clearance for deeper work).
– Continue 2–3 weeks beyond symptom resolution to support long-term tissue remodeling.

Common principle across all four: Protocol intensity matches symptom intensity. Acute flares get more frequent sessions; maintenance phases drop to 1–2× per week. Modality selection is condition-specific — laser and localized cryo dominate diabetic and CIPN protocols, IASTM leads sciatica protocols, and post-surgical work integrates with the broader rehabilitation timeline. Whole-body cryo is offered only when circulation status is appropriate and the client tolerates the cabin environment.


Building Your Nerve Therapy Protocol

Five variables shape the right protocol: underlying diagnosis and medical management plan, severity and distribution of symptoms, circulation and comorbidity status, sleep and stress impact, and treatment goals. ARC’s intake process captures all five before any modality is recommended. Below are representative protocol patterns by phase.

Initial Assessment Phase (First 2 Weeks):
– Comprehensive intake reviewing diagnosis, current medications, medical team involvement, and prior treatments.
– NeuralChek baseline assessment.
– Introduction to 2–3 modalities at conservative dosing to assess individual tolerance.
– Clear documentation of which modalities feel beneficial and which don’t.
– Coordination with primary care or neurologist where relevant — we’re happy to provide treatment summaries.

Active Symptom Management Phase (Weeks 3–12):
– Build to 2–3 ARC visits per week using the modality combinations that produced the best response in initial assessment.
– Layered protocols: laser + localized cryo on most symptomatic visits, infrared + BrainTap on regulation-focused visits.
– Track symptoms, sleep quality, and overall pain perception across the phase.
– Communicate any meaningful changes back to the medical team — particularly if symptoms worsen or new symptoms emerge.

Maintenance Phase (Beyond 12 Weeks):
– Drop to 1–2× per week once symptoms have stabilized.
– Continue NeuralChek check-ins quarterly to monitor nervous-system patterns.
– Re-escalate intensity during flare-ups, vacation/travel periods, or chemo cycle anniversaries (for CIPN populations).
– Periodic reassessment of overall trajectory in coordination with physician.

Flare Management:
– Acute symptom flares warrant temporary intensity increase — 3–4 sessions per week for 2–3 weeks, layered modalities, focus on the most symptomatic distribution.
– If a flare doesn’t respond to protocol escalation within 2–3 weeks, refer back to physician. Worsening neuropathy warrants medical evaluation — supportive modalities are not the right pathway for progressing disease.

Key Principle: Match Modality Intensity to Symptom Status, Coordinate With Medical Team Throughout. The protocols above are starting templates — real-world implementation is always individualized, always informed by the underlying medical management, and always honest about where supportive care fits in the larger picture.


Safety, Contraindications, and When to Refer Out

This section matters more for nerve therapy than for most ARC service categories, because the underlying conditions often come with comorbidities that require careful screening. Every nerve-therapy client at ARC completes an intake that captures this information — but proactive disclosure during scheduling and at intake is in the client’s best interest.

Critical Note: Severe Diabetic Neuropathy + Compromised Circulation

This is the most important safety message on this page. Severe peripheral neuropathy combined with uncontrolled diabetes and compromised peripheral circulation is a contraindication for whole-body cryotherapy. The reasoning is mechanical: peripheral neuropathy reduces or eliminates the warning signals (cold pain, discomfort) that healthy individuals use to recognize when cold exposure is becoming dangerous. Combined with compromised circulation, this creates a meaningful risk of cold-related tissue injury that wouldn’t be detected by the client during the session.

If you have diabetic peripheral neuropathy, particularly with any of the following:
– Documented peripheral arterial disease or compromised circulation
– History of foot ulcers, slow wound healing, or amputation
– Loss of protective sensation on monofilament testing
– Uncontrolled diabetes (A1c above the range your physician has targeted)

…then whole-body cryotherapy is not the right modality for you, and any ARC clinician will say so. We will, however, often have a productive supportive protocol available using Class IV laser, Infrared Cocoon, NeuralChek + BrainTap, and carefully assessed localized work. Disclosure of these conditions at intake — and physician clearance before any cryo exposure — is non-negotiable.

Whole-Body Cryotherapy Contraindications

  • Severe peripheral neuropathy with compromised circulation (see above)
  • Severe cardiovascular disease, uncontrolled hypertension, or recent cardiac event
  • Raynaud’s phenomenon or severe cold urticaria
  • Pregnancy (deferred per provider guidance)
  • Open wounds, deep vein thrombosis, peripheral arterial disease
  • Severe autonomic neuropathy affecting thermoregulation
  • Claustrophobia severe enough to prevent cabin tolerance

Localized Cryotherapy Contraindications

  • Severe sensory neuropathy in the treatment area (insufficient feedback to titrate safely)
  • Active wounds or compromised skin integrity in the treatment area
  • Peripheral arterial disease affecting the treatment area
  • Raynaud’s phenomenon affecting the treatment area
  • Active infection in the area

Class IV Laser Contraindications

  • Active malignancy in the treatment area (laser over tumor sites)
  • Pregnancy (laser over torso)
  • Epilepsy (laser over head/neck)
  • Pacemaker or implanted electronic devices (laser over chest)
  • Over photosensitive medications (some chemotherapy agents, some antibiotics — disclose all current medications at intake)

IASTM / Graston Contraindications

  • Anticoagulant medications (relative contraindication — deep work avoided)
  • Active skin conditions in the treatment area
  • Acute soft-tissue injury (first 48–72 hours post-injury)
  • Sensory neuropathy severe enough that pressure sensation is unreliable
  • Malignancy in the treatment area

Infrared Cocoon Contraindications

  • Severe autonomic neuropathy affecting heat regulation (physician clearance required)
  • Pregnancy (deferred per provider guidance)
  • Active cardiovascular instability
  • Implanted devices that contraindicate thermal exposure (verify with device manufacturer)

When ARC Refers Out

We refer back to your physician or to neurology when:
– New-onset neuropathy symptoms that haven’t been medically evaluated. ARC does not diagnose — first stop is your primary care physician or a neurologist.
– Progressive worsening of symptoms despite supportive protocols. Worsening neuropathy warrants medical workup, not modality escalation.
– New neurological signs — sudden weakness, foot drop, loss of bowel or bladder control, new sensory changes outside the existing pattern. These can indicate emergencies (cauda equina syndrome, stroke, acute disc herniation with compression) requiring immediate medical attention.
– Symptom patterns suggestive of systemic illness — unexplained weight loss, new constitutional symptoms, suspicion of autoimmune or paraneoplastic process.
– Significant cardiovascular comorbidities that we feel exceed what supportive modalities can safely accommodate.

Recovery and supportive modalities are not diagnostic. The single most important thing ARC offers in the nerve therapy space — beyond the modalities themselves — is honesty about where supportive care ends and medical management must take over.


Common Mistakes Clients Make With Nerve Therapy

Mistake #1: Treating ARC as a replacement for the neurologist. ARC is a supportive recovery facility, not a diagnostic neurology clinic. Clients who use ARC modalities instead of pursuing proper neurological workup risk missing diagnoses that require specific treatment. The right framing: ARC is one part of a coordinated picture that includes your primary care physician, your specialist where relevant, and the supportive modalities we offer.

Mistake #2: Expecting modalities to “cure” neuropathy. Most peripheral neuropathy has a structural component at the nerve fiber level that supportive modalities don’t reverse. What we often see is meaningful improvement in symptom burden — reduced burning, better sleep, less daily pain — without claiming that the underlying neuropathy itself is “cured.” Honest framing matters. Clients who arrive expecting a cure often leave disappointed; clients who arrive expecting meaningful symptom support often leave very satisfied.

Mistake #3: Skipping the circulation assessment for diabetic clients. Every diabetic neuropathy client at ARC undergoes a thoughtful circulation conversation at intake before any cold modality is offered. Clients who pressure for whole-body cryo without that assessment, or who haven’t gotten physician clearance, are doing themselves a disservice. The localized + laser pathway is genuinely effective for most diabetic neuropathy populations and avoids the cryo-related risks entirely.

Mistake #4: Inconsistent protocol attendance. Like most supportive interventions, nerve therapy protocols build effect over time. Clients who attend 2–3 sessions then drop off rarely see the meaningful symptom shifts that those who commit to a 6–12 week protocol experience. Set realistic expectations on time horizon.

Mistake #5: Stopping prescribed medications without physician input. Some clients hope ARC modalities will let them stop gabapentin, pregabalin, or duloxetine. That conversation belongs with your prescribing physician, not with ARC. We can document symptom changes for your medical team to consider — we cannot and should not advise medication changes.

Mistake #6: Treating ARC modalities as a one-time intervention. Many neuropathy conditions are chronic, and adjunctive support is most valuable as a maintenance pattern over months and years rather than as a one-time fix. Memberships and consistent attendance produce better outcomes than sporadic visits.

Mistake #7: Ignoring the sleep and stress side of chronic neural pain. Chronic pain — particularly neuropathic pain — has a substantial nervous-system regulation component. Clients who pursue only the symptom-focused modalities (laser, cryo) while ignoring sleep, stress, and the parasympathetic side (NeuralChek + BrainTap + Infrared Cocoon) often plateau earlier than those who address the full picture.


Frequently Asked Questions

Does cryotherapy help neuropathy?

The evidence is emerging, the mechanism is plausible, and many clients report meaningful symptom support — but cryotherapy is not a “treatment” for neuropathy in the way prescription medication is. The Kwiecien 2021 review documents cryotherapy’s effects on cytokine modulation, norepinephrine, and parasympathetic shift — mechanisms with reasonable application to chronic pain and recovery contexts (PMID: 33877402). Direct large-scale RCT evidence for cryotherapy specifically in peripheral neuropathy populations is still being built. At ARC, we frame cryotherapy as supportive — many clients see real benefit in overall pain perception, sleep quality, and nervous-system state. We don’t position it as a replacement for what your physician has prescribed.

Is ARC a replacement for my neurologist?

No — ARC is supportive care that works alongside your medical team. We don’t diagnose, we don’t prescribe, and we don’t manage the underlying condition. What we do is offer a clinical recovery environment with modalities that may help with symptom burden, sleep, and the nervous-system regulation side of chronic neural pain. Continue seeing your neurologist or primary care physician. Bring them updates on what you’re doing at ARC if that’s helpful. Many of our clients tell us their physicians appreciate the coordination.

Can I do cryotherapy if I have diabetic neuropathy?

It depends on your circulation status, the severity of your neuropathy, and your overall diabetes control — and the answer requires conversation, not a blanket yes or no. Severe diabetic peripheral neuropathy with compromised circulation is a contraindication for whole-body cryotherapy. Mild-to-moderate diabetic neuropathy with well-controlled diabetes, intact protective sensation, and good peripheral circulation may be appropriate for whole-body cryo — but only after a careful intake conversation and ideally physician clearance. The localized cryo + Class IV laser + Infrared Cocoon pathway is often a better fit for diabetic neuropathy clients and avoids the cryo-related risks entirely. We disclose this clearly at intake.

What about sciatica? Is the protocol the same as for peripheral neuropathy?

No — sciatica has a different mechanism and a different protocol. Sciatica is typically driven by mechanical compression or irritation of the sciatic nerve or its lumbar roots — often involving a muscular and fascial component (tight piriformis, hamstring, lumbar paraspinals) on top of the neural irritation. The lead modalities are IASTM (for the soft-tissue component), Class IV laser (along the lumbar paraspinals and sciatic distribution), and localized cryotherapy (for acute flares). Whole-body cryo serves as a systemic adjunct rather than the lead modality. The Coviello 2017 IASTM review supports soft-tissue mobilization for related conditions (PMID: 28349028), and the Malanga 2015 review supports the heat/cold mechanism background (PMID: 25526231).

How long until I notice improvement?

Most clients report some perceived change within 3–6 weeks of consistent attendance, though individual responses vary widely. Acute effects (immediate post-session pain reduction, improved sleep that night) are often felt after individual sessions. Cumulative effects on overall symptom burden, daily pain, and functional capacity typically build over 4–12 weeks of consistent protocol. Clients who attend sporadically rarely see the same trajectory as those who commit to a steady weekly cadence. We always hedge here — neuropathy responses are individualized, and ARC’s role is supportive rather than curative.

Can Class IV laser help my chemo-induced neuropathy?

Many CIPN clients report meaningful symptom support from Class IV laser, though the RCT evidence specifically for laser in CIPN is still building. The mechanism — photobiomodulation, cellular ATP support, and analgesic effects via neural pathway modulation — is documented in the Malanga 2015 review of heat and cold therapies (PMID: 25526231). At ARC, we typically introduce Class IV laser conservatively for CIPN clients and adjust based on tolerance and response. Always coordinate with your oncology team if you’re still in survivorship follow-up.

What’s a typical course of nerve therapy at ARC?

For most clients, 2–3 sessions per week for 6–12 weeks during the active phase, dropping to 1–2× per week for maintenance once symptoms stabilize. The exact protocol depends on diagnosis, symptom pattern, and how you respond to initial sessions. We reassess at 4-week intervals and adjust frequency and modality mix based on what’s working. Most clients who commit to a structured course see meaningful symptom-management benefit; those who attend sporadically see less.

Do I need a referral from my doctor?

No — ARC operates as a cash-pay clinical wellness facility without referral requirements. That said, if your condition is complex or your physician would benefit from being in the loop, we’re happy to provide treatment summaries you can share. For clients with significant comorbidities (severe diabetes, recent cardiovascular events, active oncology treatment, recent surgery), we may ask for physician clearance before specific modalities — that’s in your safety interest, not a barrier.

Can I do nerve therapy if I’m on blood thinners?

Yes, with modality adjustments. Anticoagulants (warfarin, apixaban, rivaroxaban, others) are a relative contraindication for deep IASTM work — we’ll go lighter or avoid that modality. Class IV laser, Infrared Cocoon, NeuralChek + BrainTap, and (with appropriate screening) cryotherapy modalities are generally appropriate. Disclose all current medications at intake so we can design the safest possible protocol.

Is nerve therapy at ARC covered by insurance?

No — ARC operates entirely cash-pay. This is both a limitation (you’re paying out of pocket) and an advantage (no insurance gatekeeping, no diagnosis-driven authorization process, immediate access). Single-session pricing as of 2026: localized cryotherapy in the $25–$65 range, Class IV laser $50–$100, IASTM $60–$90, BrainTap and Infrared Cocoon vary by package. Memberships run $150–$400 per month and bundle unlimited access to core services — most clients running an active 2–3× per week protocol find memberships more economical. Full pricing available by phone at (209) 314-5828 or on our pricing FAQ.

Can ARC help with post-surgical nerve pain?

Yes — post-surgical nerve recovery is one of our core nerve-therapy populations. Protocols combine Class IV laser on the surgical region and downstream neural distribution, localized cryotherapy for flare areas, IASTM on healed soft tissue (with surgeon clearance for deeper work), and BrainTap for nervous-system regulation. We coordinate timing with the broader post-surgery recovery framework — typically beginning supportive nerve work 6–12 weeks post-op once incisions are healed and the surgeon has cleared adjunctive care. Always within the guardrails the surgeon has set.

What are the main contraindications for nerve therapy modalities?

The most important: severe peripheral neuropathy with compromised circulation is a contraindication for whole-body cryotherapy. Other key contraindications across modalities include active malignancy in the treatment area, anticoagulant therapy (relative contraindication for deep IASTM), pregnancy for several modalities, severe autonomic neuropathy affecting thermoregulation, and active infection or skin breakdown in the treatment area. The full safety section earlier on this page covers these in detail. The intake process captures all relevant medical history before any modality is recommended.

Will I still need my prescribed medication if ARC modalities help?

That’s a conversation for you and your prescribing physician — not for ARC. Some clients find that adjunctive support reduces their overall symptom burden enough to support productive conversations with their physician about dosing. Others maintain their full medication regimen alongside ARC services. Either is fine. We don’t position our modalities as medication replacements, and we don’t advise medication changes. Document your experience and share it with your medical team.


Why ARC Is Different From Other Modesto Nerve Pain Options

Several Modesto and Central Valley facilities offer some overlap with ARC’s nerve-therapy services. What separates ARC from each alternative:

Neurology and pain medicine practices. These are the right setting for diagnostic workup, medication management, and procedural interventions (nerve blocks, epidural injections, etc.). ARC is the supportive complement — where you go for the recovery and symptom-management side that pharmacy and procedures alone don’t fully address. We don’t compete with neurology; we coordinate with it.

Physical therapy clinics. Quality PT clinics treat specific nerve-related diagnoses under insurance authorization, often time-limited by what insurance will cover. ARC is the cash-pay continuation — where you go when PT benefits run out, when you want continued supportive care beyond what PT visits cover, or when the multi-modal layered approach matches what you need better than focused PT sessions.

Chiropractic offices with cryo add-ons. Several Central Valley chiropractors offer cryotherapy as an auxiliary service. ARC is purpose-built for clinical recovery and operates 16+ modalities (cryo, laser, compression, IASTM, BrainTap, Infrared Cocoon, NeuralChek, and more) rather than cryo as an add-on. For neuropathy specifically, the depth of laser, infrared, and nervous-system regulation modalities makes a meaningful difference.

Acupuncture practices. Acupuncture is a respected adjunctive modality for many neural pain conditions and many of our clients use both. ARC’s offering is mechanistically distinct — photobiomodulation, cold/heat thermal therapy, instrument-assisted soft tissue work, brainwave entrainment — and works well alongside acupuncture rather than as a replacement.

Gym-based “recovery centers.” Some Central Valley gyms have added recovery zones with cryo or compression equipment. The differences relevant for neuropathy populations: ARC has licensed clinician staff (OTD/OTR-L, not fitness trainers), formal intake and screening processes, modality selection based on diagnosis and comorbidities, and the willingness to decline services or refer out when appropriate. For a population with complex comorbidities, the clinical infrastructure matters as much as the equipment.

The combined edge. 38+ years of clinical experience between co-founders Jeff and Anna Steckler. 2,000+ clients served since 2018 across athletic, chronic pain, post-surgical, and neuropathy populations. Multi-modality depth no competing Central Valley facility matches. Honest framing — supportive, not curative; adjunctive, not diagnostic. And a service area covering the full Stanislaus / San Joaquin / Merced corridor, with clients regularly traveling from Turlock, Ceres, Riverbank, Oakdale, Stockton, Tracy, Manteca, Ripon, Lodi, Merced, Patterson, Hughson, and Escalon.


Book Your Nerve Therapy Consultation

Advanced Recovery Cryotherapy
4660 Spyres Way, Modesto, CA 95356
(209) 314-5828
Book your first session

Serving Modesto, Turlock, Ceres, Riverbank, Oakdale, Stockton, Tracy, Manteca, Ripon, Lodi, Merced, Patterson, Hughson, and Escalon. Open Monday–Friday 9am–6pm, Saturday 9am–2pm.

Every nerve-therapy client begins with a thorough intake conversation — diagnosis, current medications, medical team involvement, comorbidities, symptom pattern, and treatment goals. From there we design a protocol that complements your existing care, with full transparency on where the evidence is strong, where it’s still emerging, and where supportive modalities end and medical management must lead.

Read more:
– Whole Body Cryotherapy services — pricing, mechanism, what to expect
– Localized Cryotherapy services — targeted cold protocols
– NeuralChek & BrainTap services — nervous-system assessment and entrainment
– Infrared Cocoon services — thermal therapy details
– Graston Technique & IASTM — soft tissue mobilization
– Chronic Pain Treatment in Modesto — broader chronic pain framework
– Pain Relief Therapy — pain-focused protocols
– Inflammation Treatment — inflammation-focused protocols
– Joint Pain & Knee Pain Recovery — joint-focused recovery
– Post-Surgery Recovery — post-surgical framework
– Cryotherapy Benefits & Results — benefits FAQ hub
– Conditions Cryotherapy Treats — conditions FAQ hub
– Cryotherapy Safety & Side Effects — safety FAQ hub


References

  1. Kwiecien SY, et al. (2021). “The cold truth: the role of cryotherapy in the treatment of injury and recovery from exercise.” Eur J Appl Physiol. PMID: 33877402.
  2. Malanga GA, et al. (2015). “Mechanisms and efficacy of heat and cold therapies for musculoskeletal injury.” Postgrad Med. PMID: 25526231.
  3. Coviello JP, et al. (2017). “Instrument Assisted Soft Tissue Mobilization: A Review of the Literature.” Sports Health. PMID: 28349028.
  4. Maizes V, et al. (2017). Systematic review of integrative health service delivery. PMID: 29056410.
  5. Hill J, et al. (2013). “Compression garments and recovery from exercise-induced muscle damage: a meta-analysis.” Br J Sports Med. PMID: 23315753.
  6. Brown F, et al. (2021). “Compression Garments and Recovery from Exercise: A Meta-Analysis.” Sports Med. PMID: 34234090.